Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 41.51% is in line with its 5-year average of 44.33%, around the middle of its 5-year range (31.58%–50.79%).
1.22% below its 12-month average of 42.02%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 31.58%.
GROSS MARGIN
41.51%
GROSS MARGIN AVG TTM
42.02%
GROSS MARGIN AVG 3Y
44.71%
GROSS MARGIN AVG 5Y
44.33%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.22%
CURRENT VS 3Y AVG
-7.16%
CURRENT VS 5Y AVG
-6.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.44%
median of 688 covered companies
CURRENT VS SECTOR MEDIAN
+5.25%
vs the sector median at left
Spectral AI, Inc.
Market Cap
$55.08M
Gross Margin
41.51%
TTM Avg
42.02%
3Y Avg
44.71%
5Y Avg
44.33%
Market Cap
$53.69M
Gross Margin
-29.12%
TTM Avg
13.64%
3Y Avg
-48.92%
5Y Avg
-105.92%
Market Cap
$51.99M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.91M
Gross Margin
N/A
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
16.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $55.08M | 41.51% | 42.02% | 44.71% | 44.33% |
| Aldeyra The (ALDX)vs › | $54.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $53.69M | -29.12% | 13.64% | -48.92% | -105.92% |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $57.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.91M | N/A | 50.00% | 25.00% | 16.67% |
| biote Corp. (BTMD)vs › | $51.83M | 71.46% | 70.99% | 69.42% | 67.35% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.34M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
41.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 31.58% |
| 2026-03-31 | 50.79% |
| 2025-12-31 | 39.78% |
| 2025-09-30 | 42.75% |
| 2025-06-30 | 45.21% |
| 2025-03-31 | 47.23% |
| 2024-12-31 | 44.03% |
| 2024-09-30 | 44.87% |
| 2024-06-30 | 44.32% |
| 2024-03-31 | 46.55% |
| 2023-12-31 | 46.08% |
| 2023-09-30 | 42.79% |
| 2023-06-30 | 42.13% |
| 2023-03-31 | 42.95% |
| 2022-12-31 | 41.14% |
| 2022-09-30 | 45.85% |
| 2022-06-30 | 42.44% |
| 2022-03-31 | 40.90% |
| 2021-12-31 | 46.24% |
| 2021-09-30 | 46.24% |
